ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

The Food and Drug Administration approved Augtyro for patients over the age of 12 with NTRK-positive solid tumors.

February brought in multiple FDA approvals in the oncology space. Here’s an overview of some of the most recent ones.

The Food and Drug Administration will speed up their review and potential approval of Tagrisso for certain patients with EGFR-mutant lung cancer.

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews

I believe I have hereditary cancer, especially after my daughter was approved to receive genetic testing for breast cancer.

Dato-DXd was efficacious in patients with non-small cell lung cancer with brain metastases who have certain gene alterations, a phase 2 study showed.